首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >Predicting lymphoma outcomes and risk factors in patients with primary Sjögren’s Syndrome using gradient boosting tree ensembles
【24h】

Predicting lymphoma outcomes and risk factors in patients with primary Sjögren’s Syndrome using gradient boosting tree ensembles

机译:使用梯度增强树组合预测原发性干燥综合征患者的淋巴瘤结局和危险因素

获取原文

摘要

Primary Sjogren’s Syndrome (pSS) is a chronic autoimmune disease followed by exocrine gland dysfunction, where it has been long stated that 5% of pSS patients are prone to lymphoma development. In this work, we use clinical data from 449 pSS patients to develop a first, rule-based, supervised learning model that can be used to predict lymphoma outcomes, as well as, identify prominent features for lymphoma prediction in pSS patients. Towards this direction, the gradient boosting method combined with regression tree ensembles is used to derive a rule-based, decision model for lymphoma prediction. Our results reveal an average accuracy 87.1% and area under the curve score 88%, highlighting the importance of the C4 value, the rheumatoid factor and the lymphadenopathy factor as prominent lymphoma predictors, among others.
机译:原发性干燥综合征(pSS)是继发于外分泌腺功能障碍的慢性自身免疫性疾病,长期以来,已有5%的pSS患者易患淋巴瘤。在这项工作中,我们使用来自449名pSS患者的临床数据来开发第一个基于规则的监督学习模型,该模型可用于预测淋巴瘤的预后以及确定pSS患者的淋巴瘤预测的突出特征。朝着这个方向,将梯度增强方法与回归树组合相结合,可以得出用于淋巴瘤预测的基于规则的决策模型。我们的结果显示平均准确度为87.1%,曲线下面积为88%,突出了C4值,类风湿因子和淋巴结病因子作为重要的淋巴瘤预测指标的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号